Nasdaq:US$32.06 (-0.11) | HKEX:HK$50.45 (+0.05) | AIM:£4.71 (+0)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 30 Oct 2009

Hutchison MediPharma Limited Initiates Phase I Clinical Trial of HMPL-011, Its Novel Single Chemical Drug Candidate for the Treatment of Auto-immune Diseases

1 items
a091030